NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. IDH s dual-listed ordinary shares begin trading today on the Egyptian Exchange, complementary to their trading on the LSE
(Cairo and London) - Integrated Diagnostics Holdings ( IDH, the Company or the Group, IDHC on the London Stock Exchange), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces that its EGP-denominated and dual-listed ordinary shares begin trading today on the Egyptian Exchange ( EGX ) under the ticker code IDHC.CA and ISIN code EGS99021C015
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION. THIS ANNOUNCEMENT INCLUDES INSIDE INFORMATION. IDH receives approval from the FRA for its dual listing on the Egyptian Exchange; trading expected to commence on 20 May 2021
The listing of the EGP-denominated ordinary shares will position IDH as the sole dual-listed Egyptian company on both the Egyptian Exchange and the London Stock Exchange (Cairo and London) - Further to its announcements on 22 March 2021 and 5 May 2021, Integrated Diagnostics Holdings ( IDH, the Company or the Group, IDHC on the London Stock Exchange ( the LSE )), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announce
Investegate |Integrated Diag Hdgs Announcements | Integrated Diag Hdgs: Trading update for the year ended 31 December 2020 investegate.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investegate.co.uk Daily Mail and Mail on Sunday newspapers.
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. Integrated Diagnostics Holdings ( IDH or the Company ), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces that, further to its circular posted on 4 December 2020 (the Circular ), at the Extraordinary General Meeting (the EGM ) of the Company held earlier today at the headquarters of IDH Integrated Diagnostics Holdings, Building B216-F7, Smart Village, Giza, Egypt, all resolutions contained in the notice of the meeting appended to the Circular were duly passed. Further information on the resolutions and the voting report will be available on the Company s website at https://investors.idhcorp.com/
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.
Integrated Diagnostics Holdings ( IDH or the Company ), a leading consumer healthcare company with operations in Egypt, Jordan, Sudan, and Nigeria, announces that, further to its circular posted on 4 December 2020 (the Circular ), at the Extraordinary General Meeting (the EGM ) of the Company held earlier today at the headquarters of IDH Integrated Diagnostics Holdings, Building B216-F7, Smart Village, Giza, Egypt, all resolutions contained in the notice of the meeting appended to the Circular were duly passed.
Further information on the resolutions and the voting report will be available on the Company s website at https://investors.idhcorp.com/